Philadelphia Business Journal: Antigenics buoyed by brain-cancer study

Source: Uinta County News

Agen : France | about 1 month ago

0 0

Drug developer Antigenics Inc. said researchers at the University of California , San Francisco, reported positive results stemming from a study using its cancer therapy Oncophage to treat brain-cancer patients. Brain Tumor Research Center indicated a lengthening of median survival rates —...

Reach
Credibility

More News From: Agen : France

Related Allvoices Contributions

What happens when prisoners complain of adverse reactions to certain ...

By: AnneHart

It all depends on an individual's genetic response to a particular food. People should eat more fresh fruit and vegetables, but how can they be made affordable and safe from certain pesticides? What about sensitivities to candy, soy, milk, nuts, or other foods? What helps one person may be toxic to another person. For example, prisoners may ...

about 1 month ago

News Stories

SeekingAlpha: Antigenics Should Rise on the Promise of Cancer Immunotherapy ...

News Source: Uinta County News | about 1 month ago

Monday announcing promising results for the company's Phase II trial that will measure the effectiveness of Oncophage in treating patients with recurrent high grade glioma (brain cancer). Data from the first twenty patients treated with Oncophage...
Philadelphia Business Journal: Antigenics buoyed by brain-cancer study

News Source: Uinta County News | about 1 month ago

Drug developer Antigenics Inc. said researchers at the University of California , San Francisco, reported positive results stemming from a study using its cancer therapy Oncophage to treat brain-cancer patients. Brain Tumor Research Center indicated...